LCLAT1 Antikörper (Middle Region)
-
- Target Alle LCLAT1 Antikörper anzeigen
- LCLAT1 (Lysocardiolipin Acyltransferase 1 (LCLAT1))
-
Bindungsspezifität
- Middle Region
- Reaktivität
- Maus, Human, Ratte, Kaninchen, Rind (Kuh), Hund, Meerschweinchen, Pferd
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser LCLAT1 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB)
- Sequenz
- YLYSLVKWYF IITIVIFVLQ ERIFGGLEII ELACYRLLHK QPHLNSKKNE
- Homologie
- Cow: 93%, Dog: 92%, Guinea Pig: 92%, Horse: 93%, Human: 100%, Mouse: 92%, Rabbit: 100%, Rat: 92%
- Produktmerkmale
- This is a rabbit polyclonal antibody against LYCAT. It was validated on Western Blot using a cell lysate as a positive control.
- Aufreinigung
- Affinity Purified
- Immunogen
- The immunogen is a synthetic peptide directed towards the middle region of human LYCAT
- Top Product
- Discover our top product LCLAT1 Primärantikörper
-
-
- Applikationshinweise
- Optimal working dilutions should be determined experimentally by the investigator.
- Kommentare
-
Antigen size: 376 AA
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- Lot specific
- Buffer
- Liquid. Purified antibody supplied in 1x PBS buffer with 0.09 % (w/v) sodium azide and 2 % sucrose.
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Handhabung
- Avoid repeated freeze-thaw cycles.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- For short term use, store at 2-8°C up to 1 week. For long term storage, store at -20°C in small aliquots to prevent freeze-thaw cycles.
-
-
LPS impairs oxygen utilization in epithelia by triggering degradation of the mitochondrial enzyme Alcat1." in: Journal of cell science, Vol. 129, Issue 1, pp. 51-64, (2016) (PubMed).
: "
-
LPS impairs oxygen utilization in epithelia by triggering degradation of the mitochondrial enzyme Alcat1." in: Journal of cell science, Vol. 129, Issue 1, pp. 51-64, (2016) (PubMed).
-
- Target
- LCLAT1 (Lysocardiolipin Acyltransferase 1 (LCLAT1))
- Andere Bezeichnung
- LYCAT (LCLAT1 Produkte)
- Synonyme
- lclat1 antikoerper, zgc:77380 antikoerper, wu:fj17g04 antikoerper, LYCAT antikoerper, lycat antikoerper, agpat8 antikoerper, alcat1 antikoerper, 1agpat8 antikoerper, AGPATP8 antikoerper, 1AGPAT8 antikoerper, AGPAT8 antikoerper, ALCAT1 antikoerper, HSRG1849 antikoerper, UNQ1849 antikoerper, AI181996 antikoerper, Agpat8 antikoerper, Alcat1 antikoerper, Gm91 antikoerper, Lycat antikoerper, RGD1565906 antikoerper, lysocardiolipin acyltransferase 1 antikoerper, lclat1 antikoerper, LCLAT1 antikoerper, Lclat1 antikoerper
- Hintergrund
-
LYCAT is an acyl-CoA:lysocardiolipin acyltransferase. It possesses both lysophosphatidylinositol acyltransferase (LPIAT) and lysophosphatidylglycerol acyltransferase (LPGAT) activities. LYCAT recognizes both monolysocardiolipin and dilysocardiolipin as substrates with a preference for linoleoyl-CoA and oleoyl-CoA as acyl donors. LYCAT acts as a remodeling enzyme for cardiolipin, a major membrane polyglycerophospholipid. It converts lysophosphatidic acid (LPA) into phosphatidic acid (PA) with a relatively low activity. LYCAT is required for establishment of the hematopoietic and endothelial lineages.
Alias Symbols: ALCAT1, FLJ37965, UNQ1849, LYCAT, AGPAT8, 1AGPAT8, HSRG1849
Protein Interaction Partner: LNX1, GOPC, RNF2, UBC, ELAVL1,
Protein Size: 376 - Molekulargewicht
- 44 kDa
- Gen-ID
- 253558
- NCBI Accession
- NM_001002257, NP_001002257
- UniProt
- Q6UWP7
-